Chronic kidney disease and sarcopenia a binomial installed in public health
Article Sidebar
Main Article Content
Abstract
The measurement of health-related quality of life (HRQoL) helps to determine the effects that the disease produces in the patient and the way in which it affects all aspects of their life.
In chronic renal failure (CRF) they contribute to the appearance of sarcopenia, chronic disease per se, advanced age, habitual sedentary lifestyle, added to multiple factors that deteriorate nutritional status. The presence of sarcopenia is correlated with higher mortality, disability and increased risk of falls, therefore it is associated with lower quality of life.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC public health. 2008;8(117):1-13. doi:10.1186/1471-2458-8-117
Otero A, de FA, Gayoso P, Garcia F. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia. 2010;30(1):78-86. doi: 10.3265/Nefrologia.pre2009.dic.5732.
Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis. 2003;41(5 Suppl):11-17. doi: 10.1016/s0272-6386(03)00372-x.
Levin A, Stevens PA, Blous RW, Coresh J, De Francisco A, De Jong PE, et al. Kidney Disease: improving global outcomes (KDIGO) CKD work group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–163.
Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17–28. doi: 10.1038/ki.2010.483.
Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388(10041):294–306. doi: 10.1016/S0140-6736(16)30448-2.
Liyanage T, Ninomiya T, Jha V, Neal B, Halle MP, Ikechi O, et al.. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. doi: 10.1016/S0140-6736(14)61601-9
Organización Mundial de la Salud. Programa Envejecimiento y Ciclo Vital. Envejecimiento activo: un marco político. Rev Esp Geriatr Gerontol 2002; 37(S2):74-105.
Vinaccia S, Quiceno J. Calidad de vida relacionada con la salud y enfermedad crónica: estudios colombianos. Psychol. av. discip. 2012; 6(1): 123-136.
Aparicio C, Fernández A, Garrido G, Luque-de Pablos A, Izquierdo E. Influencia de la situación clínica en la calidad de vida relacionada con la salud de los pacientes pediátricos con enfermedad renal crónica. Nefrología. 2013; 33 (1): 61-6
Julián J, Molinuevo J, Sánchez J. La situación laboral del paciente con enfermedad renal crónica en función del tratamiento sustitutivo renal. Nefrología. 2012; 32(4): 439-445
Medellín J. Carrillo G. Soporte social percibido y calidad de vida de personas con enfermedad renal crónica sometidas a trasplante renal. Revista Avances en Enfermeria. 2014;32(2): 206-216.
Cusumano AM. Sarcopenia en pacientes con y sin insuficiencia renal cronica: diagnostico, evaluación y tratamiento. Nefrologia, Dialisis y trasplante. 2015;35(1):32-43.
Real-Delor RE, Roy-Torales T, Ambrasath-Mendoza JS, Báez GN, Díaz-Ocampo FB, Domínguez-Castell PB, et al. Calidad de vida y sarcopenia en pacientes adultos con insuficiencia renal crónica. Rev. Nac. (Itauguá). 2022;14(1):30-45.
Cueto-Manzano AM, Douthat W. Enfrentando el desafío de la enfermedad renal en América Latina. Lancet. 2017.http://www.thelancet.com/campaings/kidney-disease-in-latin-america.